Lumosad, Marebeb M.
HRN: 22-80-84 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/02/2023
CEFAZOLIN 1GM (VIAL)
04/02/2023
04/03/2023
IVTT
2g
Prior To OR
For D&C
Waiting Final Action
Indication: Prophylaxis Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes